Elon Musk revealed updates on the Tesla Roadster’s design during the company’s Earnings Call, promising spectacular features like hovering capability. However, no firm release date was provided, frustrating fans eager for the long-delayed electric vehicle.
Roadster Delays Continue, Fans Left in the Dark
During Wednesday night's earnings call, many were hoping for answers about the Tesla Roadster, but CEO Elon Musk and other officials once again gave a cryptic walkaround, leaving viewers with no clear picture of what's going on.
There have been multiple instances of delays with the Roadster. Fans and owners have been asking the Roadster for years, and Tesla has a good reason—they're more focused on other vehicles and projects that contribute to the company's goal.
Empty Promises on Production Dates
There has never been an issue with Tesla coordinating production and delivery dates; for example, the company has hinted that production will begin "next year" or "by the end of" a specific date. Last night, Tesla praised the patient, but the company still hadn't given them a concrete indication of when they can expect the car, so it was all just empty rhetoric.
According to Musk:
“I’d like to thank our long-suffering deposit holders. The Roadster is not just the cherry on the cake but also the icing on the cake. We’re close to finalizing the design.”
Restricting Updates Until Tangible Progress
Obviously, all Musk said it was was a vehicle with the ability to go from zero to sixty miles per hour in 1.9 seconds and the ability to hover. But the truth is, we need to stop being evasive and just announce that the project will be delayed until further notice. There are other, more pressing matters for us.
It is okay that last night's update was something similar to this. But until something can be proved that is really there, Roadster upgrades should be restricted, given the company's concentration on other initiatives.
Hovering Capability Teased, But No Clear Timeline
Still, Musk has stated that the design is nearing completion and that it will reintroduce hovering capability:
“We are finalizing the design of [the Tesla Roadster] now. It will be something spectacular. My friend Peter Thiel was lamenting we don’t have flying cars. Well…more to come.”
No Production in Sight Despite Long-Held Deposits
Many have already paid for this car with deposits, and now they must wait for something that is clearly not in Tesla's near future. Teslarati has heard rumors about its imminent release every year, but production has not begun. The lack of a "next year" remark and the subsequent disclosure of the impending delay were both addressed last night.
He had promised in May 2023 that manufacturing would start by the year's end in 2024.
Roadster Unveil Now Pushed to 2025
Musk announced in February 2024 that the vehicle will be unveil


SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Jensen Huang Urges Taiwan Suppliers to Boost AI Chip Production Amid Surging Demand
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Instagram Outage Disrupts Thousands of U.S. Users
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



